Company Overview and News

0
Dividend Sensei's Portfolio Update 48: The Best Way To Overcome Your Biggest Investing Problem

12h seekingalpha
History has shown that long-term investing in stocks in general, and high-yield dividend growth stocks in particular, is the single best way to build wealth over time.
OMP MPLX AMGP

2
Marathon Petroleum: East Is About To Meet West In The Refining Sector

2018-08-20 seekingalpha
Eastern U.S. refiner Marathon Petroleum reported Q2 earnings that beat on both lines, launching a share price rally in the refining sector in the process.
MPLX WNR ANDV MPC

1
MPLX LP: A Strong Q2, But A Possible Acquisition Makes For An Uncertain Outlook

2018-08-20 seekingalpha
Logistics MLP MPLX LP reported Q2 earnings earlier this month that missed slightly on diluted earnings per unit despite substantially topping the revenue consensus estimate.
MPLX MPC

0
Energy Transfer Is Cooking In Grease

2018-08-14 seekingalpha
Results are undeniably strong, there's line-of-sight to major project completions, and the roll-up announcement puts an exclamation point on the corporate simplification process.
MPLX ETP WPZ EPD

1
Dividend Sensei's Portfolio Update 47: Overcoming Adversity And Soaring To New Heights

2018-08-13 seekingalpha
It's the two-year anniversary of my coming home to Minnesota after a disastrous five years that destroyed my: finances, confidence, and marriage.
AM OMP MPLX EQM NBLX DM NEP

10
Dividend Sensei's Portfolio Update 46: More Concentrated Portfolio Is Off To A Great Start

2018-08-07 seekingalpha - 1
I decided to complete my portfolio consolidation early in order to focus on my top 27 best ideas.
MPLX V NVDA AR

0
MPLX / MPLX LP 10-Q (Quarterly Report)

2018-08-06 sec.gov
Document Table of Contents
MPLX

9
Targa Resources, NextEra Energy Resources, WhiteWater Midstream and MPLX LP Execute Agreements to Jointly Develop the Whistler Pipeline Project

2018-08-03 globenewswire
HOUSTON, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE:TRGP) ("Targa"); NextEra Energy Pipeline Holdings, LLC, an indirect, wholly-owned subsidiary of NextEra Energy Resources, LLC (NYSE: NEE) (“NextEra”); WhiteWater Midstream, LLC (“WhiteWater”), a portfolio company of Denham Capital Management and Ridgemont Energy Partners; and MPLX LP (NYSE: MPLX) (“MPLX”), announced today the execution of a letter of intent (and associated term sheets) for the joint development of the proposed Whistler Pipeline Project (“Whistler Project” or the “Project”), which will provide an outlet for increased natural gas production from the Permian Basin to growing markets along the Texas Gulf Coast.
MPLX WPXP MPC TRGP WPX NEE

0
34 Dividend Increases: July 23-27, 2018 (Part 2: Non-Financials)

2018-07-30 seekingalpha
In the past week, 34 companies that match my watch criteria announced dividend increases, including one of my portfolio holdings.
TLLP MPLX VLO ANDX

4
Dividend Sensei's Portfolio Update 45: Time For Some Spring Cleaning

2018-07-30 seekingalpha
After discussing it with numerous readers as well as Brian Bain, I've decided I need to tighten up my portfolio focus.
BAMGF MPLX EPD NEP NTES BAMKF BAM NEE

6
More Midstream Momentum

2018-07-29 seekingalpha
Midstream outpaced the broad market and posted a fourth straight positive week. MLPs again led the way, with a 1.5% gain. The MLP Index is up 4.7% over those 4 weeks. The Alerian Midstream Energy Index (AMNA), the most inclusive midstream index, was up 0.9% and has posted a year-over-year total return of 0.1%, slightly ahead of the Alerian MLP Index.
TRP MPLX XOM SMLP EPD ENB XTO BPL HCLP CEQP ENB WPZ TRP WMB OKE MMP FANG

2
Record Earnings, 22 Straight Hikes, More Growth Coming, 6.8% Yield, 1.36X Coverage, Estimates Rising

2018-07-28 seekingalpha
Coverage was 1.36X in Q2, and trailing coverage is a very strong 1.29X, even with 22 quarterly distribution hikes.
MPLX MWE MS ANDV MPC

2
Marathon Petroleum (MPC) Q2 Earnings Shine on Higher Margins

2018-07-27 zacks
Independent oil refiner and marketer Marathon Petroleum Corporation (MPC - Free Report) reported strong second-quarter results on higher fuel margin and rising income from its midstream division.
MPLX EQT MRO MPC ANDV

0
MPLX / MPLX LP 8-K (Current Report)

2018-07-26 sec.gov
Document
MPLX

0
AMLP Is Finally Ready To Move

2018-07-23 seekingalpha
Midstream companies are benefiting from limited shale takeaway capacity seen in North America, which causes differentials to widen and backlogs to grow, but can have individual headline risks.
MPLX ETP WPZ MMP

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 55336V100